Risk factors associated with abnormal glucose tolerance in the early postpartum period among Japanese women with gestational diabetes

Int J Gynaecol Obstet. 2015 Apr;129(1):42-5. doi: 10.1016/j.ijgo.2014.09.030. Epub 2014 Dec 4.

Abstract

Objective: To identify the risk factors associated with abnormal glucose tolerance (AGT) on the first postpartum oral glucose tolerance test (OGTT) among Japanese women with gestational diabetes (GDM).

Methods: In a retrospective study, data were analyzed from women with GDM who underwent their first postpartum OGTT 6-8weeks post partum at a center in Omura, Japan, between January 1, 2007, and December 31, 2011. Women with diabetes or impaired glucose tolerance were deemed to have postpartum AGT. The association between postpartum AGT and various risk factors was analyzed.

Results: Among 169 women who underwent a postpartum OGTT, 58 (34.3%) had AGT. The significant risk factors associated with postpartum AGT in univariate analysis were pre-pregnancy body mass index (P=0.096), 1-hour plasma glucose (P=0.006), hemoglobin A1c (P<0.001), insulinogenic index (P=0.05), an insulinogenic index of less than 0.4 (P=0.006), and insulin therapy during pregnancy (P<0.001). Independent risk factors identified by multivariate logistic regression models were insulinogenic index (odds ratio [OR] 0.10, 95% confidence interval [CI] 0.01-0.74; P=0.002), an insulinogenic index of less than 0.4 (OR 5.70, 95% CI 1.69-21.66; P=0.005), and insulin therapy during pregnancy (OR 3.43, 95% CI 1.03-12.55; P=0.044).

Conclusion: Among Japanese women with GDM, a lower insulinogenic index and use of insulin therapy during pregnancy are associated with early postpartum AGT.

Keywords: Abnormal glucose tolerance; Gestational diabetes; Insulinogenic index; Japan; Postpartum period; Risk factors.

MeSH terms

  • Adult
  • Blood Glucose / analysis
  • Body Mass Index
  • Diabetes, Gestational / blood*
  • Diabetes, Gestational / drug therapy
  • Female
  • Glucose Intolerance / blood
  • Glucose Intolerance / etiology*
  • Glucose Tolerance Test / methods
  • Glycated Hemoglobin / analysis
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Insulin / blood
  • Insulin / therapeutic use
  • Japan
  • Postpartum Period / blood*
  • Postpartum Period / metabolism
  • Pregnancy
  • Retrospective Studies
  • Risk Factors
  • Time Factors

Substances

  • Blood Glucose
  • Glycated Hemoglobin A
  • Hypoglycemic Agents
  • Insulin
  • hemoglobin A1c protein, human